Aspen, controlled by tycoon Stephen Saad, wins Canadian approval for generic Ozempic
Billionaires Africa | 23.07.2026 02:39
Aspen Pharmacare, the drugmaker built by South African billionaire Stephen Saad, has won Health Canada approval for a generic version of Novo Nordisk's diabetes blockbuster Ozempic, though a supply failure at its ingredient partner will keep the product off Canadian shelves for months.
